Total raised
€122M
€122,366,205
Funding rounds
3
Investors
7
distinct backers
Active since
2020-08
latest 2022-01
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood39
base rate 48% for Series B
- ▼ Overdue vs cohort gap
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood24
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
- ▲ €100M+ raised
- ▲ 6y since founding
Timing: overdue vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-01-18 | Series B | €88M | Amadeus Capital Partners,Chimera Capital,Delin Ventures,Northpond Ventures,Novalis LifeSciences,Octopus Ventures+1 more | View deal → |
| 2020-10-15 | Series A | €26M | Northpond Ventures | View deal → |
| 2020-09-01 | Seed | €8.5M | — | View deal → |
Investors
7Related news
- Ori Biotech Raises Over USD100M in Series B Fundingfinsmes.com · 2022-01
- tech.eu
- finsmes.com